Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer

Lancet Oncology

Volumn 6, Issue 10, 2005, Pages 736-737

  Shapiro, Samuel ^a   Szarewski, Anne ^b   Cogliano, Vincent ^c   Grosse, Yann ^c   Baan, Robert ^c   Straif, Kurt ^c   Secretan, Bétrice ^c   El Ghissassi, Fatiha ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT; CARCINOGEN;

ARTICLE; BREAST CANCER; CANCER RESEARCH; CANCER RISK; CARCINOGENICITY; DISEASE ASSOCIATION; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HORMONAL CONTRACEPTION; HORMONE SUBSTITUTION; HUMAN; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MENOPAUSAL SYNDROME; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; UTERINE CERVIX CANCER; VALIDATION PROCESS; NOTE; PUBLISHING; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; MENOPAUSE; UTERINE CERVIX TUMOR;

CARCINOGENS; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HEALTH POLICY; HORMONE REPLACEMENT THERAPY; HUMANS; PUBLISHING; BREAST NEOPLASMS; ESTROGENS; MENOPAUSE; PROGESTINS; UTERINE CERVICAL NEOPLASMS;

EID: 26444546825     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(05)70365-X     Document Type: Letter

References (2)

1. V Cogliano Y Grosse R Baan et al. Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment Lancet Oncol 6 2005 552-553
2. IARC Monographs on the evaluation of carcinogenic risks to humans, volume 91, combined oestrogen-progestogen contraceptives and combined oestrogen-progestogen menopausal therapy. Lyon: International Agency for Research on Cancer (in press).